There is convincing evidence from the literature on Alzheimer's disease that KLK6, the most abundant kallikrein-related peptidase in the central nervous system, cleaves the amyloid precursor protein (APP), a transmembrane glycoprotein from which Aβ derives. Here, KLK6 is linked to Alzheimer disease.